Howard University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Washington DC United States (1867)

Organization Overview

First Clinical Trial
2000
NCT00006400
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Howard Uinversity | Howard University | Professor and Chair, Howard University College of Medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 4)

Anemia (Phase 3)

Anemia, Sickle Cell (Phase 3)

Behavior, Addictive (Phase 4)

Bipolar Disorder (Phase 4)

Disease (Phase 4)

Hematologic Diseases (Phase 3)

HIV Infections (Phase 4)

Immunologic Deficiency Syndromes (Phase 4)

Melanosis (Phase 4)

Opioid-Related Disorders (Phase 4)

Parkinson Disease (Phase 2)

Prostatic Neoplasms (Phase 2)

Sleep Initiation and Maintenance Disorders (Phase 4)

Stress Disorders, Post-Traumatic (Phase 4)

Stress Disorders, Traumatic (Phase 4)

Substance-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 16